HIV/AIDS News

BOSTON — Sub-Saharan African countries supported by the U.S. President’s Emergency Plan for AIDS Relief, or PEPFAR, tested for COVID-19 at three times the rate of non-PEPFAR nations, according to data presented at IDWeek.

Researchers confirmed the dosing of an ART combination designed to treat children with HIV and found that it was safe, well tolerated and efficacious through 24 weeks, according to results published in The Lancet HIV.

Five male infants in South Africa who were born with HIV were able to maintain undetectable viral loads for months despite low adherence to ART, according to researchers at the International AIDS Society Conference on HIV Science.

Compared with their peers, people with HIV experienced a smaller decline in mortality risk from COVID-19 during the omicron wave of the pandemic, researchers reported.

New HIV infections in the United States declined by around 12% from 2017 to 2021, led by large decreases among young people, according to CDC data published Tuesday.

Children are falling far behind adults when it comes to testing and treatment for HIV, according to a new study published in Pediatrics.

The United States met perinatal HIV elimination goals for the first time in 2019, according to a study led by CDC researchers.

Roughly 20 million people with HIV in 54 countries are receiving ART through the President's Emergency Plan for AIDS Relief, a 300-fold increase in 2 decades, according to a new report.

SEATTLE — Two studies presented at the Conference on Retroviruses and Opportunistic infections demonstrated high adherence levels and acceptability of long-acting, injectable PrEP for HIV prevention among varying groups of people.

SEATTLE — Recently published recommendations for the prevention of pediatric HIV infection say people with HIV should be counseled about infant feeding prior to conception or as early as possible in pregnancy.